TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
EDIT

Editas Medicine Inc

Healthcare · Biotechnology

2.70$ -0.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

Editas Medicine Inc (EDIT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -165 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow EDIT
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-8.7 -5.4 -50 -9.4 -46 -41 -180 -164 -177 -132 -210 -165
0.2 0.5 1.2 2.7 3.3 2.8 4.0 5.1 6.3 6.1 5.8 5.3
0.1 3.5 17 23 27 27 23 43 29 20 21 10
1.9 41 28 38 38 24 51 45 29
4.1 63 19 71 27 66 -102 -21 8.2 -1.6 3.5 -31
1.2 1.4 3.5 2.1 4.8 6.2 7.2 8.0 4.1 4.7 8.8 0.6
-1.2 -1.4 -5.1 -184 -53 12 -141 -54 114 -3.7 162 139
143 0.8 0.0 0.0
0.0 0.0 0.0 0.0 0.0 132 224 282 1.3
0.5 -0.5 -0.6 -1.4 -0.9
18 139 97 155 87 132 224 282 1.3 118 56 40
8.6 133 42 -39 -12 103 -96 64 -62 -18 7.9 14
-9.9 -6.8 -53 -11 -50 -47 -187 -172 -181 -137 -219 -166

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?